Search results
Showing 151 to 165 of 274 results for obesity
kidney transplant is limited in quantity and quality. For patients with obesity who would not otherwise be able to have a kidney...
suggests associations between unfavourable disturbance in gut microbiota and obesity or type 2 diabetes, but there is very limited...
obese children and young people and their families (including beliefs about obesity). Include: - ethnicity and cultural aspects -...
When should testing for gestational diabetes take place – in the first or second trimester?
for women diagnosed with gestational diabetes. However, maternal age and obesity are increasing, and some women (especially those from...
Secondary outcomes are impact on attachment between mother and child, obesity in children, autoimmune disease, chronic illness,...
it is hard to get high-quality images, for example, scoliosis and morbid obesity whether the software works in groups that could...
This guideline covers mental health rehabilitation for adults with complex psychosis. It aims to ensure people can have rehabilitation when they need it and promotes a positive approach to long-term recovery. It includes recommendations on organising rehabilitation services, assessment and care planning, delivering programmes and interventions, and meeting people’s physical healthcare needs.
heart disease, chronic kidney disease, cancer, cerebral vascular disease, obesity) Source guidance details Comes from guidance COVID-19
Pelvic floor dysfunction: prevention and non-surgical management (NG210)
This guideline covers the prevention, assessment and non-surgical management of pelvic floor dysfunction in women aged 12 and over. It aims to raise awareness and help women to reduce their risk of pelvic floor dysfunction. For women who have pelvic floor dysfunction, the guideline recommends interventions based on their specific symptoms.
This guideline covers when to offer and discuss caesarean birth, procedural aspects of the operation, and care after caesarean birth. It aims to improve the consistency and quality of care for women and pregnant people who are thinking about having a caesarean birth or have had a caesarean birth in the past and are now pregnant again.
Atezolizumab with bevacizumab for treating advanced or unresectable hepatocellular carcinoma (TA666)
Evidence-based recommendations on atezolizumab (Tecentriq) with bevacizumab (Avastin) for treating advanced or unresectable hepatocellular carcinoma in adults who have not had previous systemic treatment.
FibroScan for assessing liver fibrosis and cirrhosis outside secondary and specialist care (HTG682)
Evidence-based recommendations on FibroScan for assessing liver fibrosis and cirrhosis outside secondary and specialist care.
This guideline covers diagnosing and managing bladder cancer in people 18 and above referred from primary care with suspected bladder cancer, and those with newly diagnosed or recurrent bladder (urothelial carcinoma, adenocarcinoma, squamous-cell carcinoma or small-cell carcinoma) or urethral cancer.
Digital technologies for multidisciplinary weight management
In development Reference number: GID-HTE10077 Expected publication date: TBC
This guideline has been updated and replaced by NICE guideline NG246.